Profile
Peter S.
Linsley formerly worked at Bristol Myers Squibb Co., as Immunology Director, Merck Research Laboratories Massachusetts LLC, as Executive Director-Cancer Biology, Sarepta Therapeutics, Inc., as Chief Scientific Officer & Senior Vice President from 2011 to 2012, Rosetta Inpharmatics LLC, as Vice President-Research & Development, and Regulus Therapeutics, Inc., as Chief Scientific Officer from 2008 to 2010.
Dr. Linsley received his undergraduate degree from Auburn University and doctorate degree from the University of California, Berkeley.
Former positions of Peter S. Linsley
Companies | Position | End |
---|---|---|
SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2012 |
REGULUS THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/10/2010 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Chief Tech/Sci/R&D Officer | - |
Training of Peter S. Linsley
Auburn University | Undergraduate Degree |
University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
REGULUS THERAPEUTICS INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
SAREPTA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
- Stock Market
- Insiders
- Peter S. Linsley